FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Friday

 

Signaling Molecule Seen to Induce CNS Remyelination in Mice with Spinal Injuries

















































Neuregulin-1 is a signaling molecule of interest in the context of synaptic plasticity ­— the ability of our nerve cells to form new connections and get rid of those that are no longer needed. Now, a study showed that the factor is also indispensable for repairing myelin in models of spinal cord injury, a finding with possibly long-reaching implications for multiple sclerosis (MS) treatment.

The study, “Neuregulin-1 controls an endogenous repair mechanism after spinal cord injury,” was a collaborative effort between researchers from King’s College London and the University of Oxford, and published in the journal Brain.

Spinal cord injury and the nerve regeneration that follows have one thing in common with MS — good outcomes are highly dependent on remyelination of nerve cells. Spontaneous remyelination of damaged neurons in the spinal cord is very limited, and much research has focused on identifying factors that might speed up the natural process.

The scientists searched for these factors, analyzing a mouse model lacking the gene coding for neuregulin-1. Findings showed that when these mice suffered an injury to their spinal cord, no myelin repair whatsoever was evident.

As could be expected in the absense of remyelination, the mutant mice improved less after the injury than their normal counterparts, particularly when walking, balance, and coordination were assessed.

The research team also noted that neuregulin-1 could induce remyelinating functions in cells that normally do not hold this capacity — in so-called Schwann cells. These cells are known to myelinate nerves in the peripheral nervous system, but such an activity is unusual in the central nervous system, according to the researchers.

Elizabeth Bradbury, the study’s senior author and a professor of Regenerative Medicine & Neuroplasticity at King’s College, said in a press release: “Existing treatments are largely ineffective, so there is a pressing need for new regenerative therapies to repair tissue damage and restore function after spinal cord injury. These new findings advance our understanding of the molecular mechanisms which may orchestrate the body’s remarkable capacity for natural repair.”

Added Dr. Katalin Bartus, lead author of the study, “We hope this work will provide a platform for future research, in which it will be important to test how enhancing levels of neuregulin-1 will improve functional outcome after spinal cord injury.”

“By enhancing this spontaneous response, we may be able to significantly improve spinal cord function after injury,” Dr. Bradbury concluded. “Our research also has wider implications for other disorders of the central nervous system which share this demyelinating pathology, such as multiple sclerosis.”

Story Source: The above story is based on materials provided by MULTIPLESCLEROSISNEWSTODAY
Note: Materials may be edited for content and length

Labels:



Go to Newer News Go to Older News